Kakuta H[au] - Search Results

Year	Number of Results
1963	1
1968	1
1969	5
1970	1
1976	1
1977	1
1978	5
1979	1
1981	1
1982	1
1983	1
1985	4
1986	4
1987	1
1988	2
1989	2
1990	2
1991	1
1992	1
1993	3
1995	4
1996	9
1997	3
1998	1
1999	3
2000	2
2001	6
2002	6
2003	10
2004	5
2005	3
2006	4
2007	6
2008	8
2009	2
2010	8
2011	10
2012	5
2013	4
2014	6
2015	4
2016	2
2017	4
2018	6
2019	10
2020	6
2021	6
2022	6
2023	4
2024	1

1

Simple Fluorescence Labeling Method Enables Detection of Intracellular Distribution and Expression Level of Retinoid X Receptors.

Tanaka Y, Fujihara M, Takamura Y, Kawasaki M, Nakano S, Makishima M, Kakuta H. Tanaka Y, et al. Among authors: kakuta h. ACS Med Chem Lett. 2024 Apr 23;15(5):640-645. doi: 10.1021/acsmedchemlett.4c00033. eCollection 2024 May 9. ACS Med Chem Lett. 2024. PMID: 38746897

2

Direct evaluation of polarity of the ligand binding pocket in retinoid X receptor using a fluorescent solvatochromic agonist.

Miura K, Fujihara M, Watanabe M, Takamura Y, Kawasaki M, Nakano S, Kakuta H. Miura K, et al. Among authors: kakuta h. Bioorg Med Chem Lett. 2023 Nov 15;96:129536. doi: 10.1016/j.bmcl.2023.129536. Epub 2023 Oct 30. Bioorg Med Chem Lett. 2023. PMID: 37913851

3

Characterization and Interconversion of Two Crystal Forms of NEt-3IB, a Retinoid X Receptor Agonist.

Takamura Y, Kikuzawa S, Fujihara M, Sunatsuki Y, Higaki K, Kakuta H. Takamura Y, et al. Among authors: kakuta h. Chem Pharm Bull (Tokyo). 2023;71(4):282-288. doi: 10.1248/cpb.c22-00817. Chem Pharm Bull (Tokyo). 2023. PMID: 37005253 Free article.

4

Ligand Screening System for the RXRα Heterodimer Using the Fluorescence RXR Agonist CU-6PMN.

Kawasaki M, Motoyama T, Yamada S, Watanabe M, Fujihara M, Kambe A, Nakano S, Kakuta H, Ito S. Kawasaki M, et al. Among authors: kakuta h. ACS Med Chem Lett. 2023 Feb 20;14(3):291-296. doi: 10.1021/acsmedchemlett.2c00509. eCollection 2023 Mar 9. ACS Med Chem Lett. 2023. PMID: 36923911 Free PMC article.

5

Structural characterization of 1,3-bis-tert-butyl monocyclic benzene derivatives with agonistic activity towards retinoid X receptor alpha.

Kodama S, Matsumoto S, Takamura Y, Fujihara M, Watanabe M, Ono A, Kakuta H. Kodama S, et al. Among authors: kakuta h. Toxicol Lett. 2023 Jan 15;373:76-83. doi: 10.1016/j.toxlet.2022.11.003. Epub 2022 Nov 9. Toxicol Lett. 2023. PMID: 36368620

6

Analysis of absorption-enhancing mechanisms for combinatorial use of spermine with sodium taurocholate in Caco-2 cells.

Maruyama M, Nishida Y, Tanaka H, Minami T, Ogawara KI, Miyake M, Takamura Y, Kakuta H, Higaki K. Maruyama M, et al. Among authors: kakuta h. Eur J Pharm Biopharm. 2022 Nov;180:332-343. doi: 10.1016/j.ejpb.2022.10.020. Epub 2022 Oct 25. Eur J Pharm Biopharm. 2022. PMID: 36307000

7

Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene.

Takamura Y, Kato I, Fujita-Takahashi M, Azuma-Nishii M, Watanabe M, Nozaki R, Akehi M, Sasaki T, Hirano H, Kakuta H. Takamura Y, et al. Among authors: kakuta h. ACS Pharmacol Transl Sci. 2022 Aug 10;5(9):811-818. doi: 10.1021/acsptsci.2c00126. eCollection 2022 Sep 9. ACS Pharmacol Transl Sci. 2022. PMID: 36110376 Free PMC article.

8

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo.

Khazan N, Kim KK, Hansen JN, Singh NA, Moore T, Snyder CWA, Pandita R, Strawderman M, Fujihara M, Takamura Y, Jian Y, Battaglia N, Yano N, Teramoto Y, Arnold LA, Hopson R, Kishor K, Nayak S, Ojha D, Sharon A, Ashton JM, Wang J, Milano MT, Miyamoto H, Linehan DC, Gerber SA, Kawar N, Singh AP, Tabdanov ED, Dokholyan NV, Kakuta H, Jurutka PW, Schor NF, Rowswell-Turner RB, Singh RK, Moore RG. Khazan N, et al. Among authors: kakuta h. J Med Chem. 2022 Apr 28;65(8):6039-6055. doi: 10.1021/acs.jmedchem.1c01878. Epub 2022 Apr 11. J Med Chem. 2022. PMID: 35404047 Free PMC article.

9

Increased Molecular Flexibility Widens the Gap between K _i and K _d values in Screening for Retinoid X Receptor Modulators.

Watanabe M, Nakamura-Nakayama M, Fujihara M, Kawasaki M, Nakano S, Kakuta H. Watanabe M, et al. Among authors: kakuta h. ACS Med Chem Lett. 2022 Jan 21;13(2):211-217. doi: 10.1021/acsmedchemlett.1c00575. eCollection 2022 Feb 10. ACS Med Chem Lett. 2022. PMID: 35178177 Free PMC article.

10

Development of Scaled-Up Synthetic Method for Retinoid X Receptor Agonist NEt-3IB Contributing to Sustainable Development Goals.

Takamura Y, Morishita KI, Kikuzawa S, Watanabe M, Kakuta H. Takamura Y, et al. Among authors: kakuta h. Chem Pharm Bull (Tokyo). 2022;70(2):146-154. doi: 10.1248/cpb.c21-00911. Chem Pharm Bull (Tokyo). 2022. PMID: 35110435 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year